- Medicine Name: Focus V
- API: Anlotinib Hydrochloride
- Dosage Form & Strength: Capsules: 12 mg
- Manufactured By: Sino Biopharm Ltd
Anlotinib hydrochloride is a novel small molecule multi-target tyrosine kinase inhibitor used for the treatment of advanced NSCLC, soft1s tissue sarcomas, small cell lung cancer, advanced or metastatic medullary thyroid cancer (MTC), and differentiated thyroid cancer (DTC).
Recommended Dosage: The recommended dosage of Anlotinib hydrochloride can vary depending on the specific type of cancer being treated and individual patient factors. Anlotinib Hydrochloride capsules are usually taken orally with water. Swallow the capsules whole; do not crush or open them unless instructed otherwise by your healthcare provider. Take the capsules with or without food, depending on your healthcare provider’s instructions.
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.